Bortezomib induces apoptosis via the JNK/p38 MAPK pathway in esophageal squamous cell carcinoma, multiple myeloma cells, and glioblastoma cells [22,36,37]. This evidence concerns the gene MAPK8 and plasma cell myeloma.